ALPHA TRIBE

Alembic Pharmaceuticals LimitedImportant, 31-05-2025: Updates

31-05-2025 | 11:13 pm

Alembic Pharmaceuticals’ API-I & II facility at Panelav completed a USFDA inspection with four observations, none related to data integrity. Management considers these issues manageable and will submit a detailed response. The company continues to prioritize high-quality standards and regulatory compliance.

No comments yet. Be the first to comment!

All announcements from Alembic Pharmaceuticals Limited